Alexion Pharmaceuticals Inc (ALXN) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Alexion Pharmaceuticals Inc   (NASDAQ: ALXN)
 

Alexion Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALXN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 13.27 % 15.75 % 15.08 % 14.89 %
Q / Q Revenue Growth (Q1 MRQ) 2.81 % -3.77 % -2.3 % 2.02 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 18.24 % 10.82 % 6.93 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 3.16 % 3.54 % 3.56 % 3.64 %
Revenue 5 Year Average Growth 18.44 % 15.56 % 10.85 % 9.03 %


ALXN's Growth Comparisons in I. Quarter 2021




Alexion Pharmaceuticals Inc 's 13.27% year on year Revenue increase in the first quarter 2021 to 1.64 billions, marks slow-down from Alexion Pharmaceuticals Inc 's growth trends, and competes unfavorably to the 15.75% rise in the Major Pharmaceutical Preparations industry and 15.08% Revenue improvement in the Healthcare sector. Although both, the Major Pharmaceutical Preparations industry and the Healthcare sector posted higher gains than 14.89% overall market increase, Alexion Pharmaceuticals Inc was trailing overall market in the first quarter.

Comparing the company's Revenue to the fourth quarter results, sales were higher by 2.81% . On the yearly basis, average annual sales growth for Alexion Pharmaceuticals Inc is 18.44%, while S & P 500's including only Businesses with the first quarter 2021 earnings, average annual sales growth is 9.03% over the past five years.

ALXN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential


Growth Rates of ALXN's Income in the first quarter 2021


ALXN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -8.53 % 19.66 % 32.5 % 92.71 %
Sequential Operating Income Change (Q1 MRQ) 2.27 % - 83.38 % 58.11 %
Y / Y Operating Income Growth (Q1 TTM) -75.08 % -33.09 % -12.74 % -6.23 %
Sequential Operating Income Growth (Q1 TTM) -9.38 % 7.46 % 9.28 % 19.42 %
Operating Income 5 Year Avg. Change 3.33 % 9.21 % 2.2 % 8.2 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -12.27 % 40.47 % 44.46 % 153.38 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) -8.7 % - 144.66 % 61.73 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -77.46 % -36.29 % -13.56 % 0.07 %
Sequential Income from Cont. Ops. Change (Q1 TTM) -11.34 % 24.46 % 15.74 % 28.52 %
Income from Cont. Ops. 5 Year Avg. Change 33.11 % 22.71 % 10.33 % 76.07 %

ALXN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -12.27 % 31.34 % 39.36 % 144.01 %
Q / Q Net Income Growth (Q1 MRQ) -8.7 % - 654.36 % 64.84 %
Y / Y Net Income Change (Q1 TTM) -77.46 % -38.78 % -19.18 % -0.39 %
Sequential Net Income Change (Q1 TTM) -11.34 % 21.35 % 17.16 % 27.86 %
Net Income 5 Year Avg. Growth 33.11 % 9.2 % 1.77 % 4.21 %

ALXN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 14.68 % 5.06 % 44.46 % 153.38 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 18.93 % - 144.66 % 61.73 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -70.68 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 13.45 % - - 34.47 %
EPS from Cont. Ops. 5 Year Avg. Growth 32.14 % 8.14 % 10.33 % 76.07 %



ALXN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 14.4 % -1.77 % 39.36 % 76.07 %
Q / Q EPS Net Growth (Q1 MRQ) 18.67 % - 654.36 % 64.84 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - 105.19 % - -27.73 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 13.38 % 545.6 % - 32.32 %
EPS Net 5 Year Avg. Change 32.34 % 9.2 % 1.77 % 4.21 %



Alexion Pharmaceuticals Inc bucks the industry trend and shows 14.4% year on year EPS increase in the first quarter to $2.86, while Major Pharmaceutical Preparations industry declined by -1.77%, Healthcare sector increased 39.36%. Slow first quarter 2021 income per share, in Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in the Alexion Pharmaceuticals Inc results which underperformed overall market.

The bottom-line improved by 18.67% from the fourth quarter. Looking into annual income per share rise of 32.34%, and S & P 500's average yearly income per share growth is 4.21% over the five years, including only Businesses with the first quarter 2021 earnings reports. Alexion Pharmaceuticals Inc grew faster than the market.

ALXN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -5.58 % 60.65 % 101.87 % 156.25 %
Sequential Free Cash Flow Change (Q1 MRQ) -33.5 % -31.66 % -24.35 % -39.04 %
Y / Y Free Cash Flow Change (Q1 TTM) 38.75 % 31.9 % 40.36 % -12.8 %
Sequential Free Cash Flow Change (Q1 TTM) -1.04 % 7.72 % 10.43 % 8.85 %
Free Cash Flow 5 Year Avg. Change 49.42 % 18.63 % 14.45 % 20.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - -84.63 % -75.89 %
Sequential Net Cash Flow Change (Q1 MRQ) -33.17 % - - -1.91 %
Y / Y Net Cash Flow Change (Q1 TTM) 16.41 % - - 12.22 %
Sequential Net Cash Flow Change (Q1 TTM) - - - -43.24 %
Net Cash Flow 5 Year Avg. Change 36.3 % 49.51 % 45.88 % 111.43 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 967.21 % 5.75 % 6.55 % 1.87 %
Sequential Capital Expenditures Change (Q1 MRQ) 68 % -38.57 % -27.85 % -22.75 %
Y / Y Capital Expenditures Change (Q1 TTM) 61.77 % 11.7 % 2.01 % -10.89 %
Sequential Capital Expenditures Change (Q1 TTM) 110.59 % 0.5 % 1.16 % 0.11 %
Capital Expenditures 5 Year Avg. Change - 17.08 % 11.27 % 9.33 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.